novartis_window

Novartis’ investigational combo impresses in breast cancer sub-group

August 23, 2018
Research and Development Cancer, Novartis, breast cancer, fulvestrant, pharma

Novartis has revealed positive new data for its investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) combined with fulvestrant in the treatment …

vagus_nerve_stimulation

Nerve stimulation treatments improve quality of life in depressed people, study shows

August 23, 2018
Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators

Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …

allergan

FDA refuses Allergan’s uterine bleeding therapy with a request for more data

August 22, 2018
Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma

Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …

34390755362_841335d219_z

Brexit Health Alliance calls for effective planning for no-deal Brexit

August 22, 2018
Research and Development Brexit Health Alliance, Labour, NHS, brexit, no-deal

Niall Dickson, co-chair of the Brexit Health Alliance has called for immediate comprehensive and effective plans for a no deal …

bristol_university_from_cabot_tower

Novo Nordisk buys Bristol University biotech in £620m deal

August 22, 2018
Research and Development Bristol, Novo Nordisk, Ziylo, diabetes

Novo Nordisk has bought a tiny biotech company spun out of Bristol University in a deal that could be worth …

darpa_big_data

Blockchain deployed in fight against fake pharmaceuticals in India

August 22, 2018
Research and Development India, NITI, blockchain, pharma, technology

Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …

Alex Azar says his agency has the power to eliminate pharmaceutical rebates

August 21, 2018
Research and Development Alex Azar, Rebates, Trump, US government, pbm

US Health and Human Services Secretary Alex Azar has said in an interview with Reuters, that it is within the …

novo_nordisk_flag

Novo’s semaglutide hits the mark in Phase 3 type 2 diabetes study

August 21, 2018
Manufacturing and Production, Research and Development Novo Nordisk, diabetes, pharma, semaglutide, type 2 diabetes

Novo Nordisk has revealed new Phase 3a data on its glucagon-like peptide-1 (GLP-1) analogue oral semaglutide in the treatment of …

28246711066_52e38bc591_z

Leaked letter warns of NHS disruption after Brexit

August 21, 2018
Manufacturing and Production NHS, The Times, brexit, hard Brexit

NHS Providers, the membership organisation and trade association for professionals working in the NHS, has warned that the NHS is …

astrazeneca_sign_sky

Japan approves AstraZeneca’s Tagrisso in EGFRm non-small cell lung cancer

August 21, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, Japan, Tagrisso, lung cancer, pharma

AstraZeneca has revealed that its EGFR tyrosine kinase inhibitor Tagrisso (osimertinib) has been approved in Japan by the nation’s Ministry …

Further six officials fired from China FDA

August 21, 2018
Manufacturing and Production CFDA, Changsheng biotechnology, China, Vaccine, scandal

A further six senior officials from the China Food and Drug Administration (CFDA) have been fired in relation to the …

30614937102_31ec4db2fa_z

Prozac prevents cognitive decline during normal aging process, study shows

August 21, 2018
Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience

A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …

Image Credit: Bristol-Myers Squibb

FDA approves Bristol Myers Squibb’s Opdivo in small-cell lung cancer

August 20, 2018
Sales and Marketing Bristol-Myers Squibb, FDA, approval, bristol myers squibb, lung cancer, opdivo

The FDA has approved Bristol Myers Squibb’s Opdivo (nivolumab) for patients with metastatic small-cell lung cancer (SCLC), as the first …

ipos0_l

Regeneron’s Eylea wins FDA approval for wet age-related macular degeneration

August 20, 2018
Sales and Marketing Bayer, Eylea, FDA, Regeneron, US, pharma

Regeneron is celebrating the approval in the US of its vascular endothelial growth factor (VEGF) inhibitor Eylea (aflibercept) for the …

Thyroid medication recalled after Chinese supplier fails inspection

August 20, 2018
Sales and Marketing China, FDA, recall, thyroid, westminster

The Mississippi based manufacturer Westminster Pharmaceuticals is voluntarily recalling thyroid medications Levothyroxine and Liothyronine after the Chinese company Sichuan Friendly …

More children suffering from type 2 diabetes in England and Wales

August 20, 2018
Sales and Marketing England, NHS, Wales, children, diabetes, obesity, young people

The number of children and young people suffering from type-2 diabetes has increased in England in Wales over the past …

Chinese regulators approve Roche’s Alecensa in regulatory shift

August 20, 2018
Sales and Marketing Cancer, China, Roche, approval, lung cancer

China’s National Drug Administration has granted rapid approval for Roche’s lung cancer treatment Alecensa (alectinib). Chinese regulators have in the …

andrew_cheng

Gilead CMO announces departure alongside two new exec appointments

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, pharma

Gilead has announced that its Chief Medical Officer is to vacate the role after just five months and leave the …

hero-plus

FDA approves first-ever generic EpiPen versions, courtesy of Teva

August 17, 2018
Medical Communications, Sales and Marketing FDA, Mylan, Teva, US, epipen, pharma

The FDA has announced the approval of the first generic versions of Mylan’s EpiPen and EpiPen Jr epinephrine auto-injectors as …

top_10_image

Top Ten most popular articles on Pharmafile.com this week

August 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10

This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …

The Gateway to Local Adoption Series

Latest content